Efficacy and Safety of GR1802 in Patients With Moderate‐to‐Severe Atopic Dermatitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial
2025 · Dermatologic Therapy · 1 citations
https://doi.org/10.1155/dth/6903760
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
41
Citations
3
h-index
1
i10-index
Yunsheng Liang is an academic researcher from Central South University. The author has contributed to research in topics: Dermatology and Skin Diseases & Inflammasome and immune disorders & Stress Responses and Cortisol. The author has an h-index of 3, co-authored 12 publications.
https://doi.org/10.1155/dth/6903760
https://doi.org/10.1016/j.jaad.2025.05.709
Click to start Chat